Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes

Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconver...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 10; p. e110480
Main Authors Tallon, Benjamin J. M., Bruneau, Julie, Tsoukas, Christos M., Routy, Jean-Pierre, Kiani, Zahra, Tan, Xianming, Bernard, Nicole F.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 17.10.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.
AbstractList Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.
Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.
Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface killer immunoglobulin-like receptor locus KIR3DL1/S1 have been shown to influence time to AIDS in HIV-infected individuals and risk of seroconversion in HIV exposed seronegative (HESN) subjects. Here, we assessed time to seroconversion or duration of seronegative status in a group of 168 HIV exposed individuals, including 74 seroconverters and 94 HESN based on carriage or not of KIR3DL1/S1/HLA-B genotypes previously shown to be associated with protection from infection and/or slow time to AIDS. KIR3DL1/S1 genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed to four-position resolution to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. KIR3DL1/S1 heterozygotes became HIV infected significantly faster than KIR3DS1 homozygotes. Individuals who carried both KIR3DS1 and Bw4*80I did not remain HIV seronegative longer than those from a control group who were homozygous for HLA-Bw6 and carried no HLA-A locus Bw4 alleles Subjects who were *h/*y+B*57 showed a trend towards slower time to serconversion than those with other KIR3DL1 homozygous and KIR3DL1/S1 heterozygous genotypes. Thus, KIR3DS1 homozygosity is associated with protection from HIV infection while co-carriage of KIR3DS1 and Bw4*80I is not. The requirements for protection from HIV infection can differ from those that influence time to AIDS in HIV infected individuals.
Audience Academic
Author Kiani, Zahra
Routy, Jean-Pierre
Tan, Xianming
Tsoukas, Christos M.
Tallon, Benjamin J. M.
Bernard, Nicole F.
Bruneau, Julie
AuthorAffiliation 2 Division of Experimental Medicine, McGill University, Montréal, Québec, Canada
5 Division of Clinical Immunology and Allergy, McGill University Health Centre, Montréal, Québec, Canada
4 Family Medicine Department, Université de Montréal, Montréal, Québec, Canada
3 Centre de recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada
1 Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada
7 Biostatistics Core Facility, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada
6 Immunodeficiency Service and Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montréal, Québec, Canada
Karolinska Institutet, Sweden
AuthorAffiliation_xml – name: 6 Immunodeficiency Service and Division of Hematology, Royal Victoria Hospital, McGill University Health Centre, Montréal, Québec, Canada
– name: 3 Centre de recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada
– name: 7 Biostatistics Core Facility, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada
– name: Karolinska Institutet, Sweden
– name: 4 Family Medicine Department, Université de Montréal, Montréal, Québec, Canada
– name: 1 Research Institute of the McGill University Health Centre (RI MUHC), Montréal, Québec, Canada
– name: 2 Division of Experimental Medicine, McGill University, Montréal, Québec, Canada
– name: 5 Division of Clinical Immunology and Allergy, McGill University Health Centre, Montréal, Québec, Canada
Author_xml – sequence: 1
  givenname: Benjamin J. M.
  surname: Tallon
  fullname: Tallon, Benjamin J. M.
– sequence: 2
  givenname: Julie
  surname: Bruneau
  fullname: Bruneau, Julie
– sequence: 3
  givenname: Christos M.
  surname: Tsoukas
  fullname: Tsoukas, Christos M.
– sequence: 4
  givenname: Jean-Pierre
  surname: Routy
  fullname: Routy, Jean-Pierre
– sequence: 5
  givenname: Zahra
  surname: Kiani
  fullname: Kiani, Zahra
– sequence: 6
  givenname: Xianming
  surname: Tan
  fullname: Tan, Xianming
– sequence: 7
  givenname: Nicole F.
  surname: Bernard
  fullname: Bernard, Nicole F.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25330014$$D View this record in MEDLINE/PubMed
BookMark eNqNk11v0zAUhiM0xLbCP0AQCQnBRTo7dpKGC6RSxlpRMbROu7Uc56R1ldrFdsr673HWFjXThFAuYh0_73s-dHwenCitIAheY9THJMMXS90Yxev-2of7CGNEB-hZcIZzEkdpjMjJ0fk0OLd2iVBCBmn6IjiNE0IQwvQs-H0rVxA6Hc7AaKHVBoyVWoVShePJXXR5v9YWynDWFEsQzoYjbsxWqnn402jnI3IDYatpbPjDy46i3yc35OsMX0xxyFUZjqfD6Et4BUq77Rrsy-B5xWsLr_b_XjD7dnk7GkfT66vJaDiNRJrHLspxhoAWRVkVosxFlWY8g4yLtCSlyEt_JoWoOMnpgPCkFDEHCqWgScw9RHrB253rutaW7SdmGU4xoTHJ_WR6wWRHlJov2drIFTdbprlkDwFt5owbJ0UNrKI4ozhNCkwxHWQVrxDkokjKlOTYj9p7fd5na4qVrwKUM7zumHZvlFywud4wGiOc-IJ6wYe9gdG_GrCOraQVUNdcgW4e6k7iZJBm2KPvHqFPd7en5tw3IFWlfV7RmrIhxQMa0wS1aftPUP4rYSX9TkAlfbwj-NgReMbBvZvzxlo2md38P3t912XfH7EL4LVbWF03zm-k7YJvjif9d8SHvfbApx0gjLbWQMWEdLz18a3JmmHE2kd0GBprHxHbPyIvpo_EB_9_yv4Ap4If4Q
CitedBy_id crossref_primary_10_1128_JVI_00933_19
crossref_primary_10_1128_JVI_01546_15
crossref_primary_10_1371_journal_ppat_1007398
crossref_primary_10_17533_udea_iatreia_216
crossref_primary_10_1155_2017_9163719
crossref_primary_10_12688_f1000research_53683_1
crossref_primary_10_4049_jimmunol_1701370
crossref_primary_10_12688_f1000research_11818_2
crossref_primary_10_1371_journal_pone_0238347
crossref_primary_10_1080_1744666X_2020_1732820
crossref_primary_10_3390_v16101584
crossref_primary_10_1097_QAD_0000000000001735
crossref_primary_10_1186_s12865_018_0272_x
crossref_primary_10_1371_journal_pone_0225151
crossref_primary_10_1038_srep22902
crossref_primary_10_3390_v14061143
crossref_primary_10_1186_s12879_020_4786_5
crossref_primary_10_1089_aid_2019_0172
crossref_primary_10_3389_fimmu_2022_879124
crossref_primary_10_1186_s12981_017_0172_9
crossref_primary_10_1371_journal_pone_0185160
crossref_primary_10_1155_2022_1119611
Cites_doi 10.4049/jimmunol.173.3.1819
10.1182/blood-2009-09-245746
10.1182/blood-2006-08-040238
10.1016/S0092-8674(00)80110-5
10.1016/j.it.2009.01.006
10.1084/jem.20070695
10.1093/aje/kwq479
10.1097/QAD.0b013e32833dfc20
10.1016/S1074-7613(00)80394-5
10.1089/aid.2006.0165
10.1182/blood-2009-08-238469
10.4049/jimmunol.171.11.5663
10.1128/JCM.43.12.6197-6199.2005
10.4049/jimmunol.171.1.477
10.1371/journal.pbio.1001208
10.1093/hmg/ddp538
10.1073/pnas.0503594102
10.1086/314621
10.1172/JCI43998
10.4049/jimmunol.178.1.235
10.4049/jimmunol.178.2.647
10.1097/QAD.0b013e3282ffde7e
10.1002/eji.1830271203
10.1097/QAD.0b013e3282f56b23
10.1371/journal.ppat.1003867
10.4049/jimmunol.166.12.7260
10.1038/ng934
10.1007/978-1-60761-362-6_25
10.1086/655971
10.4049/jimmunol.166.5.2992
10.4049/jimmunol.158.11.5237
10.1093/infdis/jit349
10.1093/nar/gkp879
10.1001/jama.280.1.42
10.1038/ng2035
10.1093/oxfordjournals.aje.a114646
10.1084/jem.20091010
10.2307/2531529
10.1038/382722a0
10.1093/infdis/jir020
10.4049/jimmunol.137.11.3671
10.1038/nature10237
10.1182/blood-2008-02-137521
10.1084/jem.181.3.1133
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Tallon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Tallon et al 2014 Tallon et al
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Tallon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Tallon et al 2014 Tallon et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0110480
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale in Context: Opposing Viewpoints
Gale in Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database (ProQuest)
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
ProQuest Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


Agricultural Science Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Influence of KIR/HLA Genotype on Time to HIV Infection
EISSN 1932-6203
ExternalDocumentID 1613423920
oai_doaj_org_article_f4174165b141487faf0e9cb5d6391193
PMC4201542
3464316891
A418424502
25330014
10_1371_journal_pone_0110480
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Canada
Montreal Quebec Canada
GeographicLocations_xml – name: Canada
– name: Montreal Quebec Canada
GrantInformation_xml – fundername: Canadian Institutes of Health Research
  grantid: 103230
– fundername: Canadian Institutes of Health Research
  grantid: 254
– fundername: Canadian Institutes of Health Research
  grantid: HVI-79515
– fundername: Canadian Institutes of Health Research
  grantid: HOP-123800
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PYCSY
RNS
RPM
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
PJZUB
PPXIY
PQGLB
PV9
RIG
RZL
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c692t-9170e4bbdfbcd9cf67a7e7ac6d3dc9d7e73bcfa39483a5dc2ae4edc452aac63
IEDL.DBID M48
ISSN 1932-6203
IngestDate Thu Nov 25 14:37:15 EST 2021
Wed Aug 27 00:48:23 EDT 2025
Thu Aug 21 18:06:17 EDT 2025
Fri Jul 11 12:35:33 EDT 2025
Fri Jul 25 10:38:40 EDT 2025
Tue Jun 17 20:42:57 EDT 2025
Tue Jun 10 20:12:36 EDT 2025
Fri Jun 27 04:51:56 EDT 2025
Fri Jun 27 03:58:54 EDT 2025
Thu May 22 21:22:09 EDT 2025
Mon Jul 21 06:07:08 EDT 2025
Tue Jul 01 03:26:39 EDT 2025
Thu Apr 24 22:50:19 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-9170e4bbdfbcd9cf67a7e7ac6d3dc9d7e73bcfa39483a5dc2ae4edc452aac63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceived and designed the experiments: NFB BT. Performed the experiments: BT. Analyzed the data: BT NFB XT ZK. Contributed reagents/materials/analysis tools: JB CMT J-PR. Contributed to the writing of the manuscript: BT JB CMT J-PR ZK XT NFB.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0110480
PMID 25330014
PQID 1613423920
PQPubID 1436336
ParticipantIDs plos_journals_1613423920
doaj_primary_oai_doaj_org_article_f4174165b141487faf0e9cb5d6391193
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4201542
proquest_miscellaneous_1615258671
proquest_journals_1613423920
gale_infotracmisc_A418424502
gale_infotracacademiconefile_A418424502
gale_incontextgauss_ISR_A418424502
gale_incontextgauss_IOV_A418424502
gale_healthsolutions_A418424502
pubmed_primary_25330014
crossref_citationtrail_10_1371_journal_pone_0110480
crossref_primary_10_1371_journal_pone_0110480
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-10-17
PublicationDateYYYYMMDD 2014-10-17
PublicationDate_xml – month: 10
  year: 2014
  text: 2014-10-17
  day: 17
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References JE Gumperz (ref26) 1997; 158
MP Martin (ref18) 2002; 31
RE Horton (ref1) 2010; 202
J Bruneau (ref36) 2001; 164
ref11
SE Hiby (ref8) 2010; 120
J Bruneau (ref29) 2011; 173
R Song (ref25) 2014; 10
T Graef (ref9) 2009; 206
ref16
S Ravet (ref3) 2007; 109
K Pelak (ref34) 2011; 9
D Scott-Algara (ref2) 2003; 171
P Brodin (ref49) 2009; 30
JA Traherne (ref14) 2010; 19
AM Wan (ref35) 1986; 137
E Martro (ref37) 2005; 43
CA Stewart (ref7) 2005; 102
CM Gardiner (ref13) 2001; 166
FR Guerini (ref20) 2011; 203
S Boulet (ref23) 2008; 22
J Robinson (ref12) 2010; 38
R Brookmeyer (ref40) 1987; 43
ref5
R Brookmeyer (ref41) 1987; 126
R Biassoni (ref6) 1997; 27
G Alter (ref46) 2007; 204
GM Gillespie (ref47) 2007; 23
S Kulkarni (ref33) 2010; 612
ref30
ref32
MP Martin (ref22) 2007; 39
C Tomescu (ref4) 2010; 24
JP Vivian (ref48) 2011; 479
M Samson (ref31) 1996; 382
ref39
GM Gillespie (ref17) 2007; 23
G Alter (ref38) 2003; 171
G Alter (ref24) 2007; 204
G Katz (ref10) 2001; 166
NF Bernard (ref28) 1999; 179
C Fauriat (ref51) 2010; 115
S Boulet (ref44) 2008; 22
J Bruneau (ref27) 2011; 173
C Fauriat (ref50) 2010; 115
JE Gumperz (ref15) 1995; 181
G Alter (ref42) 2011; 476
M Stern (ref43) 2008; 112
RN Koehler (ref21) 2013; 208
MP Martin (ref45) 2007; 39
S Boulet (ref19) 2008; 22
11207248 - J Immunol. 2001 Mar 1;166(5):2992-3001
17272507 - Blood. 2007 May 15;109(10):4296-305
18502829 - Blood. 2008 Aug 1;112(3):708-10
19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72
11276542 - CMAJ. 2001 Mar 20;164(6):767-73
12134147 - Nat Genet. 2002 Aug;31(4):429-34
21814282 - Nature. 2011 Aug 4;476(7358):96-100
21362739 - Am J Epidemiol. 2011 May 1;173(9):1049-58
21398398 - J Infect Dis. 2011 May 1;203(9):1235-9
19875415 - Nucleic Acids Res. 2010 Jan;38(Database issue):D863-9
23922366 - J Infect Dis. 2013 Oct 15;208(8):1250-4
16141329 - Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13224-9
16333129 - J Clin Microbiol. 2005 Dec;43(12):6197-9
8751444 - Nature. 1996 Aug 22;382(6593):722-5
15265913 - J Immunol. 2004 Aug 1;173(3):1819-25
9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9
17496894 - Nat Genet. 2007 Jun;39(6):733-40
18025129 - J Exp Med. 2007 Nov 26;204(12):3027-36
14634071 - J Immunol. 2003 Dec 1;171(11):5663-7
20033654 - Methods Mol Biol. 2010;612:365-75
8756719 - Cell. 1996 Aug 9;86(3):367-77
9430221 - Immunity. 1997 Dec;7(6):753-63
9164941 - J Immunol. 1997 Jun 1;158(11):5237-41
20972337 - J Clin Invest. 2010 Nov;120(11):4102-10
17202323 - J Immunol. 2007 Jan 15;178(2):647-51
18317000 - AIDS. 2008 Mar 12;22(5):595-9
22140359 - PLoS Biol. 2011 Nov;9(11):e1001208
3427161 - Biometrics. 1987 Dec;43(4):739-49
19903900 - Blood. 2010 Feb 11;115(6):1166-74
20647906 - AIDS. 2010 Sep 10;24(14):2151-60
7532677 - J Exp Med. 1995 Mar 1;181(3):1133-44
19965656 - Blood. 2010 Mar 18;115(11):2167-76
9660362 - JAMA. 1998 Jul 1;280(1):42-8
17182560 - J Immunol. 2007 Jan 1;178(1):235-41
20887228 - J Infect Dis. 2010 Nov 1;202 Suppl 3:S377-81
19282243 - Trends Immunol. 2009 Apr;30(4):143-9
19959527 - Hum Mol Genet. 2010 Mar 1;19(5):737-51
12817033 - J Immunol. 2003 Jul 1;171(1):477-88
2431040 - J Immunol. 1986 Dec 1;137(11):3671-4
17411378 - AIDS Res Hum Retroviruses. 2007 Mar;23(3):451-5
22020283 - Nature. 2011 Nov 17;479(7373):401-5
18614872 - AIDS. 2008 Jul 31;22(12):1487-91
11390475 - J Immunol. 2001 Jun 15;166(12):7260-7
3647718 - Am J Epidemiol. 1987 Jul;126(1):14-24
9952359 - J Infect Dis. 1999 Mar;179(3):538-47
24453969 - PLoS Pathog. 2014 Jan;10(1):e1003867
References_xml – ident: ref11
  doi: 10.4049/jimmunol.173.3.1819
– volume: 115
  start-page: 1166
  year: 2010
  ident: ref50
  article-title: Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
  publication-title: Blood
  doi: 10.1182/blood-2009-09-245746
– volume: 109
  start-page: 4296
  year: 2007
  ident: ref3
  article-title: Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
  publication-title: Blood
  doi: 10.1182/blood-2006-08-040238
– ident: ref30
  doi: 10.1016/S0092-8674(00)80110-5
– volume: 30
  start-page: 143
  year: 2009
  ident: ref49
  article-title: NK cell education: not an on-off switch but a tunable rheostat
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2009.01.006
– volume: 204
  start-page: 3027
  year: 2007
  ident: ref46
  article-title: Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
  publication-title: J Exp Med
  doi: 10.1084/jem.20070695
– volume: 173
  start-page: 1049
  year: 2011
  ident: ref29
  article-title: Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwq479
– volume: 24
  start-page: 2151
  year: 2010
  ident: ref4
  article-title: Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e32833dfc20
– ident: ref32
  doi: 10.1016/S1074-7613(00)80394-5
– volume: 164
  start-page: 767
  year: 2001
  ident: ref36
  article-title: Sex-specific determinants of HIV infection among injection drug users in Montreal
  publication-title: CMAJ
– volume: 23
  start-page: 451
  year: 2007
  ident: ref17
  article-title: Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2006.0165
– volume: 115
  start-page: 2167
  year: 2010
  ident: ref51
  article-title: Regulation of human NK-cell cytokine and chemokine production by target cell recognition
  publication-title: Blood
  doi: 10.1182/blood-2009-08-238469
– volume: 171
  start-page: 5663
  year: 2003
  ident: ref2
  article-title: Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.11.5663
– volume: 43
  start-page: 6197
  year: 2005
  ident: ref37
  article-title: Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.12.6197-6199.2005
– volume: 171
  start-page: 477
  year: 2003
  ident: ref38
  article-title: Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.1.477
– volume: 9
  start-page: e1001208
  year: 2011
  ident: ref34
  article-title: Copy number variation of KIR genes influences HIV-1 control. 1
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.1001208
– volume: 19
  start-page: 737
  year: 2010
  ident: ref14
  article-title: Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex 10
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddp538
– volume: 102
  start-page: 13224
  year: 2005
  ident: ref7
  article-title: Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0503594102
– volume: 179
  start-page: 538
  year: 1999
  ident: ref28
  article-title: Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons
  publication-title: J Infect Dis
  doi: 10.1086/314621
– volume: 120
  start-page: 4102
  year: 2010
  ident: ref8
  article-title: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. 4
  publication-title: J Clin Invest
  doi: 10.1172/JCI43998
– ident: ref16
  doi: 10.4049/jimmunol.178.1.235
– ident: ref5
  doi: 10.4049/jimmunol.178.2.647
– volume: 22
  start-page: 1487
  year: 2008
  ident: ref44
  article-title: A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3282ffde7e
– volume: 27
  start-page: 3095
  year: 1997
  ident: ref6
  article-title: Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830271203
– volume: 22
  start-page: 595
  year: 2008
  ident: ref19
  article-title: Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3282f56b23
– volume: 10
  start-page: e1003867
  year: 2014
  ident: ref25
  article-title: HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003867
– volume: 166
  start-page: 7260
  year: 2001
  ident: ref10
  article-title: Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.12.7260
– volume: 31
  start-page: 429
  year: 2002
  ident: ref18
  article-title: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
  publication-title: Nat Genet
  doi: 10.1038/ng934
– volume: 612
  start-page: 365
  year: 2010
  ident: ref33
  article-title: KIR genotyping by multiplex PCR-SSP
  publication-title: Methods Mol Biol
  doi: 10.1007/978-1-60761-362-6_25
– volume: 202
  start-page: S377
  year: 2010
  ident: ref1
  article-title: Cohorts for the study of HIV-1-exposed but uninfected individuals: benefits and limitations
  publication-title: J Infect Dis
  doi: 10.1086/655971
– volume: 166
  start-page: 2992
  year: 2001
  ident: ref13
  article-title: Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.5.2992
– volume: 158
  start-page: 5237
  year: 1997
  ident: ref26
  article-title: Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor
  publication-title: J Immunol
  doi: 10.4049/jimmunol.158.11.5237
– volume: 208
  start-page: 1250
  year: 2013
  ident: ref21
  article-title: Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa. 6
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jit349
– volume: 173
  start-page: 1049
  year: 2011
  ident: ref27
  article-title: Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwq479
– volume: 38
  start-page: D863
  year: 2010
  ident: ref12
  article-title: IPD–the Immuno Polymorphism Database
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp879
– volume: 204
  start-page: 3027
  year: 2007
  ident: ref24
  article-title: Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
  publication-title: J Exp Med
  doi: 10.1084/jem.20070695
– ident: ref39
  doi: 10.1001/jama.280.1.42
– volume: 479
  start-page: 401
  year: 2011
  ident: ref48
  article-title: Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature
– volume: 39
  start-page: 733
  year: 2007
  ident: ref22
  article-title: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
  publication-title: Nat Genet
  doi: 10.1038/ng2035
– volume: 126
  start-page: 14
  year: 1987
  ident: ref41
  article-title: The prevalent cohort study and the acquired immunodeficiency syndrome
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a114646
– volume: 22
  start-page: 1487
  year: 2008
  ident: ref23
  article-title: A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e3282ffde7e
– volume: 206
  start-page: 2557
  year: 2009
  ident: ref9
  article-title: KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C
  publication-title: J Exp Med
  doi: 10.1084/jem.20091010
– volume: 39
  start-page: 733
  year: 2007
  ident: ref45
  article-title: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
  publication-title: Nat Genet
  doi: 10.1038/ng2035
– volume: 43
  start-page: 739
  year: 1987
  ident: ref40
  article-title: Biases in prevalent cohorts
  publication-title: Biometrics
  doi: 10.2307/2531529
– volume: 382
  start-page: 722
  year: 1996
  ident: ref31
  article-title: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
  publication-title: Nature
  doi: 10.1038/382722a0
– volume: 23
  start-page: 451
  year: 2007
  ident: ref47
  article-title: Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2006.0165
– volume: 203
  start-page: 1235
  year: 2011
  ident: ref20
  article-title: Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jir020
– volume: 137
  start-page: 3671
  year: 1986
  ident: ref35
  article-title: The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes
  publication-title: J Immunol
  doi: 10.4049/jimmunol.137.11.3671
– volume: 476
  start-page: 96
  year: 2011
  ident: ref42
  article-title: HIV-1 adaptation to NK-cell-mediated immune pressure
  publication-title: Nature
  doi: 10.1038/nature10237
– volume: 112
  start-page: 708
  year: 2008
  ident: ref43
  article-title: Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 36
  publication-title: Blood
  doi: 10.1182/blood-2008-02-137521
– volume: 181
  start-page: 1133
  year: 1995
  ident: ref15
  article-title: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
  publication-title: J Exp Med
  doi: 10.1084/jem.181.3.1133
– reference: 21362739 - Am J Epidemiol. 2011 May 1;173(9):1049-58
– reference: 17411378 - AIDS Res Hum Retroviruses. 2007 Mar;23(3):451-5
– reference: 16141329 - Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13224-9
– reference: 24453969 - PLoS Pathog. 2014 Jan;10(1):e1003867
– reference: 9660362 - JAMA. 1998 Jul 1;280(1):42-8
– reference: 20033654 - Methods Mol Biol. 2010;612:365-75
– reference: 22020283 - Nature. 2011 Nov 17;479(7373):401-5
– reference: 23922366 - J Infect Dis. 2013 Oct 15;208(8):1250-4
– reference: 20647906 - AIDS. 2010 Sep 10;24(14):2151-60
– reference: 18502829 - Blood. 2008 Aug 1;112(3):708-10
– reference: 19959527 - Hum Mol Genet. 2010 Mar 1;19(5):737-51
– reference: 17272507 - Blood. 2007 May 15;109(10):4296-305
– reference: 17496894 - Nat Genet. 2007 Jun;39(6):733-40
– reference: 11390475 - J Immunol. 2001 Jun 15;166(12):7260-7
– reference: 9952359 - J Infect Dis. 1999 Mar;179(3):538-47
– reference: 11207248 - J Immunol. 2001 Mar 1;166(5):2992-3001
– reference: 18025129 - J Exp Med. 2007 Nov 26;204(12):3027-36
– reference: 9464792 - Eur J Immunol. 1997 Dec;27(12):3095-9
– reference: 16333129 - J Clin Microbiol. 2005 Dec;43(12):6197-9
– reference: 18317000 - AIDS. 2008 Mar 12;22(5):595-9
– reference: 12817033 - J Immunol. 2003 Jul 1;171(1):477-88
– reference: 19858347 - J Exp Med. 2009 Oct 26;206(11):2557-72
– reference: 8756719 - Cell. 1996 Aug 9;86(3):367-77
– reference: 20887228 - J Infect Dis. 2010 Nov 1;202 Suppl 3:S377-81
– reference: 20972337 - J Clin Invest. 2010 Nov;120(11):4102-10
– reference: 15265913 - J Immunol. 2004 Aug 1;173(3):1819-25
– reference: 7532677 - J Exp Med. 1995 Mar 1;181(3):1133-44
– reference: 11276542 - CMAJ. 2001 Mar 20;164(6):767-73
– reference: 19875415 - Nucleic Acids Res. 2010 Jan;38(Database issue):D863-9
– reference: 17182560 - J Immunol. 2007 Jan 1;178(1):235-41
– reference: 14634071 - J Immunol. 2003 Dec 1;171(11):5663-7
– reference: 3647718 - Am J Epidemiol. 1987 Jul;126(1):14-24
– reference: 18614872 - AIDS. 2008 Jul 31;22(12):1487-91
– reference: 21814282 - Nature. 2011 Aug 4;476(7358):96-100
– reference: 22140359 - PLoS Biol. 2011 Nov;9(11):e1001208
– reference: 12134147 - Nat Genet. 2002 Aug;31(4):429-34
– reference: 2431040 - J Immunol. 1986 Dec 1;137(11):3671-4
– reference: 21398398 - J Infect Dis. 2011 May 1;203(9):1235-9
– reference: 19282243 - Trends Immunol. 2009 Apr;30(4):143-9
– reference: 3427161 - Biometrics. 1987 Dec;43(4):739-49
– reference: 17202323 - J Immunol. 2007 Jan 15;178(2):647-51
– reference: 8751444 - Nature. 1996 Aug 22;382(6593):722-5
– reference: 9430221 - Immunity. 1997 Dec;7(6):753-63
– reference: 9164941 - J Immunol. 1997 Jun 1;158(11):5237-41
– reference: 19903900 - Blood. 2010 Feb 11;115(6):1166-74
– reference: 19965656 - Blood. 2010 Mar 18;115(11):2167-76
SSID ssj0053866
Score 2.2822628
Snippet Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface...
Natural killer (NK) cells play a role in the clearance of viral infections. Combinations of alleles at the polymorphic HLA-B locus and the NK cell surface...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e110480
SubjectTerms Acquired immune deficiency syndrome
Adult
AIDS
AIDS (Disease)
Alleles
Amino acids
Antigens
Biology and life sciences
Blood & organ donations
Cell surface
Exposure
Female
Genetic aspects
Genetic Association Studies
Genotype
Genotypes
Genotyping
Haplotypes
Health aspects
Health risks
Heterozygotes
Histocompatibility antigen HLA
HIV
HIV Infections - genetics
HIV Infections - immunology
HIV Infections - virology
HIV Seropositivity - genetics
HIV Seropositivity - immunology
HIV-1 - genetics
HIV-1 - immunology
HIV-1 - pathogenicity
HLA antigens
HLA-A Antigens - genetics
HLA-A Antigens - immunology
HLA-B Antigens - genetics
HLA-B Antigens - immunology
Homozygosity
Homozygotes
Human immunodeficiency virus
Humans
Immunoglobulins
Immunology
Infection
Infections
Killer Cells, Natural - immunology
Ligands
Loci
Major histocompatibility complex
Male
Medicine
Medicine and health sciences
Middle Aged
Natural killer cells
Physical Sciences
Polymerase chain reaction
Potassium channels (inwardly-rectifying)
Primers
Receptors, KIR3DL1 - genetics
Seroconversion
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8FChiEBDxkbRw7aR47YGphgLTCtDfLdmyYNCVV3Qj-fO4SN2rQpPHAW2Sf83F3Pt85dz8T8ipzoEcQBsRCCxHDTCxinVkRz7S1FtqTQmCh8Ocv2eI7_3ghLvaO-sKcsA4euGPcxPEEnQahEw6ee-6Um9rCaFHC0pqA94HWFx62C6Y6GwyzOMtCoVyaJ5Mgl6N1XdkjXPE4wkDuLUQtXn9vlUfrq9pf53L-nTm5txSd3CV3gg9J5927H5BbtrpHDsIs9fRNgJJ-e5_8wgoPuq0pKFrdJpi3u2P0sqKL5Xlsf69rb0vqG43bMZ4atdlg3RMN8A1gCimOaTytYNhe66flWfp-lUxOE6qqki5O5_ExRcBX3NP1D8jq5MO3d4s4HLUQm6xgWzB5-dRyrUunTVkYl-Uqt7kyWZmWpijhOtXGqbTgs1SJ0jBlOXCBC6aAKH1IRvAW9pBQZ7WxRoFgiowbCOfSGVNTA2GTSwVEIxFJd1yXJqCQ42EYV7L9tZZDNNIxUaKsZJBVROJ-1LpD4biB_hgF2tMihnbbAJolg2bJmzQrIs9RHWRXkNpbAjnnEBUzLqYsIi9bCsTRqDBR54dqvJfLr-f_QLQ6GxC9DkSuBnYYFYoj4JsQn2tAOR5QgjUwg-5DVN4dV7wEj74FeWTAlPFOoa_vftF3400x-a6yddPSCCYQCDEijzr97znLMDsZwuyI5IOZMWD9sKe6_NnCmHOG_jt7_D9k9YTchrtxdCqSfExG201jn4K3uNXPWsPwB6-NZ8s
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxMbHsg0wCAl4yJo4dtI8oW6stLANtLJpb5HtOGPSlJSmFfz53DluaNAEvFX2OU3ufOc7--5nQl7FBcwjCAN8oYTwQRNTX8VG-ANljIH2MBVYKHx8Eo_P-McLceE23GqXVrmyidZQ55XGPfI-eCYWrI4F72bffbw1Ck9X3RUat8mdEFYaTOkajD6sLDHochy7crkoCftOOnuzqjR7uO5xBINcW44san9rm3uz66q-yfH8M39ybUEaPSD3nSdJh43oN8gtU26Su8furHyTbDi1rekbhy399iH5gSUfdFFRsBGVzTi322X0qqTjybl_-HNW1SanYE5wf6amB3I-x0Io-qXBcwDbSHHMsqYnMGyt9dPkNHo_DftHIZVlTsdHQ3-fwh9XuMlbPyLT0eHXg7Hv7l7wdZyyBdjAJDBcqbxQOk91EScyMYnUcR7lOs3hd6R0IaOUDyIpcs2k4cAQLpgEougx6ZXA5S1CC6O00RL8xDTmGuK7aMBkoCGOKiIB4YlHopUAMu1gyfF2jOvMnrUlEJ40_MxQbJkTm0f8dtSsgeX4B_0-yralRVBt21DNLzOno1nBQ_RPhQo5BIlJIYvApFqJHLy4ED7AI89xZmRNhWprGrIhhzCZcREwj7y0FAisUWLmzqVc1nU2-Xz-H0TT0w7Ra0dUVMAOLV21BHwTAnZ1KHc7lGAedKd7C-fxiit19luRYORqbt_c_aLtxodiNl5pqqWlEUwgMqJHnjSq0HKWYboyxN0eSTpK0mF9t6e8-mZxzTlDh55t__21dsg9oOPoP4TJLukt5kvzFBzDhXpmtf8XgThibg
  priority: 102
  providerName: ProQuest
Title Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes
URI https://www.ncbi.nlm.nih.gov/pubmed/25330014
https://www.proquest.com/docview/1613423920
https://www.proquest.com/docview/1615258671
https://pubmed.ncbi.nlm.nih.gov/PMC4201542
https://doaj.org/article/f4174165b141487faf0e9cb5d6391193
http://dx.doi.org/10.1371/journal.pone.0110480
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1db9Mw0BrdCy-I8bVAKQYhAQ_ZmsSOmweE2tLSwlamlk19ixzHGZOqpDStGC_8du6cNFpQ-XixKvucyue78519H4S89BOgIzADbB5xbgMnBnbka253Iq019DsBx0Dh04k_Omcf53y-R7Y1W0sE5jtNO6wndb5aHF1_-_EOGP6tqdognO2ko2WW6iM8z1gHjPh9OJsE1jQ4ZdW7AnC3eb1ErcX23bZXBtP96Su1w8rk9K8kd2O5yPJdaunv3pU3jqvhXXKn1DNptyCMA7Kn03vkoOTknL4u002_uU--YxQIXWcUxEZmnNDNDRq9SulofGEPrpdZrmMKEgavbHLal6sVxkbRsyLFA4hLinM2OZ3AtBu9n8ZT7_3MOT5xqExjOjrp2j0Kf5zhvW_-gMyGgy_9kV2WY7CVH7hrEIuirVkUxUmk4kAlvpBCC6n82ItVEMNvL1KJ9ALW8SSPlSs1Ayww7koA8h6SRgqoPSQ00ZHSSsImBD5TYPJ5HVe2FZhWicfBYrGIt8V6qMpM5VgwYxGa5zcBFkuBxBD3Kiz3yiJ2NWtZZOr4B3wPN7SCxTzbpiNbXYYl24YJ0BCorDxyGNiNIpFJWwcq4jEodg4swCLPkBzCImi1khZhl4Hl7DLedi3ywkBgro0UnXku5SbPw_Hni_8Amk1rQK9KoCQDdChZBlDAmjCHVw2yWYMEiaFqw4dIvFus5CFo_SYRpAtIaW4Jevfw82oYP4oOeqnONgaGuxyTJVrkUUH_FWZd9GAGU9wiosYZNdTXR9KrrybVOXNRx3cf_31BT8htgGOoUjiiSRrr1UY_BV1xHbXILTEX0Hb6DrbDDy2y3xtMzqYtc_vSMuIB25-DX6wXbPM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkYAXxMbHAoMZBII9ZG0cO2keEOo-Sks_QOuY9kTkOM6YNCWlaTX4n_gjuUuc0qAJeNlbZZ_T5O788519dybkpZeAHoEbYItICBtmYmBHnhZ2O9JaQ7sTCEwUHo293mf-4VScrpGfVS4MhlVWmFgAdZwp3CNvgmVSFKtjrXfTbzbeGoWnq9UVGqVaDPSPS3DZ8rf9A5DvK8a6h8f7PdvcKmArL2BzmN1-S_MoipNIxYFKPF_62pfKi91YBTH8diOVSDfgbVeKWDGpuY4VF0wCkQtPvUFuchfWccxL776vcB-Qw_NMcp7rO02jC7vTLNW7uMpyLD25svgVdwQsV4LG9CLLrzJz_4zWXFn-uvfIXWO30k6paOtkTacb5NbInMxvkHUDEjl9YypZ79wnl5hgQucZBUTKivj2YnOOnqe01z-xD79Ps1zHFMALd4Nyui9nM0y7op_K6hGAxBTHLHI6hmErrYP-kXswcZpDh8o0pr1hx96j8McZbinnD8jkGmTykDRS4PImoYmOlFYSrNLA4wq8SbfNZEuB15a4Apwhi7iVAEJliqDjXRwXYXGy54MzVPIzRLGFRmwWsZejpmURkH_Q76Fsl7RYwrtoyGZnoUGEMOEOWsMicji4pH4ik5YOVCRisBkd-ACLbKNmhGU-7BKIwg4Hp5xx0WIWeVFQYBmPFOOEzuQiz8P-x5P_IJoc1YheG6IkA3YoaXIz4JuwPFiNcqtGCWCkat2bqMcVV_Lw97SFkZVuX939fNmND8XYv1Rni4JGMIF1GC3yqJwKS84yDI4GL98ifm2S1Fhf70nPvxZV1DlD94E9_vtrbZPbvePRMBz2x4Mn5A6M4Wi5OP4WacxnC_0UTNJ59KxAAkq-XC_w_AK_TKIY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGkSZeEBt_FhjMIBDwkLVx7KR5QKhrV7W0K9MK056IHMcZk6akNK0G34yPx13ihgZNwMveKvucJue7n-_suzMhL70E5AjcAFtEQtigiYEdeVrY7UhrDe1OIDBR-GjiDT7zD2fibIP8XOXCYFjlChMLoI4zhXvkTbBMimJ1rNVMTFjEca__fvbNxhuk8KR1dZ1GKSIj_eMK3Lf83bAHc_2Ksf7hp-7ANjcM2MoL2AI03W9pHkVxEqk4UInnS1_7UnmxG6sght9upBLpBrztShErJjXXseKCSSBy4am3yG3f9duoYe1uFVwCKOJ5JlHP9Z2mkYv9WZbqfVxxOZahXFsIi_sCqlWhMbvM8utM3j8jN9eWwv49ctfYsLRTCt0W2dDpNtk8Mqf022TLAEZO35iq1m_vkytMNqGLjAI6ZUWse7FRRy9SOhie2offZ1muYwpAhjtDOe3K-RxTsOhxWUkCUJnimGVOJzBsrXU0PHF7U6c5dqhMYzoYd-wDCn-c4fZy_oBMb2BOHpJGClzeITTRkdJKgoUaeFyBZ-m2mWwp8OASV4BjZBF3NQGhMgXR8V6Oy7A45fPBMSr5GeK0hWbaLGJXo2ZlQZB_0B_g3Fa0WM67aMjm56FBhzDhDlrGInI4uKd-IpOWDlQkYrAfHfgAi-yhZIRlbmwFSmGHg4POuGgxi7woKLCkR4rKcS6XeR4OP57-B9H0pEb02hAlGbBDSZOnAd-EpcJqlLs1SgAmVeveQTlecSUPf6swjFzJ9vXdz6tufCjGAaY6WxY0ggmsyWiRR6UqVJxlGCgNHr9F_JqS1Fhf70kvvhYV1TlDV4I9_vtr7ZFNgJxwPJyMnpA7MISjEeP4u6SxmC_1U7BOF9GzAggo-XKzuPMLq4imGQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Time+to+Seroconversion+in+HIV-Exposed+Subjects+Carrying+Protective+versus+Non+Protective+KIR3DS1%2FL1+and+HLA-B+Genotypes&rft.jtitle=PloS+one&rft.au=Tallon%2C+Benjamin+J.+M&rft.au=Bruneau%2C+Julie&rft.au=Tsoukas%2C+Christos+M&rft.au=Routy%2C+Jean-Pierre&rft.date=2014-10-17&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=9&rft.issue=10&rft_id=info:doi/10.1371%2Fjournal.pone.0110480&rft.externalDocID=A418424502
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon